Yahoo Search Busca da Web

Resultado da Busca

  1. Há 5 dias · Colorectal cancer, also known as bowel cancer, is a cancer formed by uncontrolled cell growth in the colon or rectum (parts of the large intestine), or in the appendix. Genetic analysis shows that ...

  2. Há 2 dias · Treatment of advanced colorectal cancer (CRC) has seen a rapid succession of significant advances, from the introduction of novel conventional cytotoxics (such as oxaliplatin and irinotecan) to, more recently, the antiangiogenic agent bevacizumab and epidermal growth factor-receptor antibodies, such as cetuximab and panitumumab.

  3. Há 5 dias · Colorectal cancer that has returned or progressed after treatment and spread to other organs is known as metastatic colorectal cancer (mCRC). Most people with mCRC survive only about two years. A trial led by Jason M. Redman, M.D. , Assistant Research Physician in the Center for Immuno-Oncology , is studying combination immunotherapy, including a tumor-targeted vaccine, for the disease.

  4. Há 5 dias · The “appearing” and “disappearing” ascites in the treatment of colorectal cancer - A case report. Hong-Ming Cui. Dong Peng. Zhengqiang Wei. Xing-Ye Wu. Frontiers in Oncology. doi 10.3389/fonc.2024.1372812. Part of a multidisciplinary journal, this section focuses on the investigation of tumorigenesis, prevention, early detection and ...

  5. Há 3 dias · There Is No Care Without Collaboration: Management of Metastatic Colorectal Cancer. Join us for a symposium on metastatic colorectal cancer designed to encourage the exchange of ideas between leaders in the field and attendees. Authors: Marwan Fakih, MD; Cathy Eng, MD, FACP; Arvind N. Dasari, MD, MS; Phuong K. Ly-Gallagher.

  6. Há 4 dias · Improving survival in metastatic colorectal cancer through optimized patient selection. June 2024. Clinical advances in hematology & oncology: H&O 22 Suppl 4 (5):1-20. June 2024. 22 Suppl 4 (5):1 ...